This information was published on 2025-03-07T14:24:20 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2525722 (IR 1841713) |
| (220) |
08 Jan 2025
|
| (300) |
KR, 12 Jul 2024, 4020240128270
KR, 12 Jul 2024, 4020240128271 |
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 5
Vaccines; enzymes for veterinary purposes; ferments for pharmaceutical purposes; pharmaceutical agents for epidermis; cellular function activating agents for medical purposes; medicinal creams for skin care; enzymes for medical purposes; enzyme preparations for medical purposes; medicines for human purposes; enzyme preparations for medical purposes containing recombinant human hyaluronidase as an active ingredient; enzymes for medical purposes containing recombinant human hyaluronidase; medicated skin care preparations. Class 42 Research and development of siRNA drugs; scientific research; research and development of vaccines and medicines; biomedical research services; drug discovery services; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; pharmaceutical research services; research on the subject of pharmaceuticals; pharmaceutical drug development services; development of gene-based medicines; technical research in the field of pharmaceutical studies; testing of pharmaceuticals; consultancy in the field of testing, inspection, research of medical products; medical research services. |
| (540) | HYDIZYME |
| (550) | Word |
| (730) |
HuonsLab Co., Ltd.
|
Find out more about publications on the About page.